{"id":84807,"date":"2020-10-08T19:01:21","date_gmt":"2020-10-08T16:01:21","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/crisprs-nobel-prize-sent-gene-editing-stocks-into-overdrive\/"},"modified":"2020-10-08T19:01:21","modified_gmt":"2020-10-08T16:01:21","slug":"crisprs-nobel-prize-sent-gene-editing-stocks-into-overdrive","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/crisprs-nobel-prize-sent-gene-editing-stocks-into-overdrive\/","title":{"rendered":"#CRISPR\u2019s Nobel Prize sent gene-editing stocks into overdrive"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_85 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-6a414ce78690d\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #dd3333;color:#dd3333\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #dd3333;color:#dd3333\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-6a414ce78690d\" checked aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/buradabiliyorum.com\/en\/crisprs-nobel-prize-sent-gene-editing-stocks-into-overdrive\/#Wall_Street_rates_CRISPR-powered_stocks\" >Wall Street rates CRISPR-powered stocks<\/a><\/li><\/ul><\/nav><\/div>\n<p>&#8220;<strong>#CRISPR\u2019s Nobel Prize sent gene-editing stocks into overdrive<\/strong>&#8221;<\/p>\n<div>\n                                Biotech stocks continued to surge on Wednesday after two scientists responsible for gene-editing tool CRISPR\u00a0<a rel=\"nofollow noopener noreferrer\" target=\"_blank\" href=\"https:\/\/www.sciencemag.org\/news\/2020\/10\/crispr-revolutionary-genetic-scissors-honored-chemistry-nobel\">received this year\u2019s Nobel Prize<\/a> for Chemistry.<\/p>\n<p>CRISPR-powered stocks Intellia Therapeutics (NTLA), Editas Medicine (EDIT), and Beam Therapeutics (BEAM) have now jumped 13%, 11%, and 6% respectively.<\/p>\n<p>CRISPR Therapeutics (CRSP), co-founded by one of the Nobel winners\u00a0<span>Emmanuelle Charpentier,\u00a0<\/span>is also up more than 11% since Wednesday morning.<\/p>\n<figure class=\"post-image post-mediaBleed alignnone\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1322417 lazy\" alt=\"\" width=\"1227\" height=\"750\" sizes=\"auto, (max-width: 1227px) 100vw, 1227px\" src=\"https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2020\/10\/Screenshot-2020-10-08-at-16.17.26.png\" data-lazy=\"true\" srcset=\"https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2020\/10\/Screenshot-2020-10-08-at-16.17.26.png 1227w, https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2020\/10\/Screenshot-2020-10-08-at-16.17.26-280x171.png 280w, https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2020\/10\/Screenshot-2020-10-08-at-16.17.26-442x270.png 442w, https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2020\/10\/Screenshot-2020-10-08-at-16.17.26-221x135.png 221w, https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2020\/10\/Screenshot-2020-10-08-at-16.17.26-796x487.png 796w\"\/><\/figure>\n<p>Collectively, these four CRISPR stocks are now worth nearly $12.2 billion\u00a0<span>\u2014<\/span> up from $6.5 billion in February with nearly $430 million added to their market values overnight.<\/p>\n<p>Now valued beyond $7.1 billion, CRSP is by far the biggest CRISPR-centric company on the market. And it\u2019s the best performing of the four above, having returned 65% so far. Tennessee-headquartered NTLA is second with 63%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Wall_Street_rates_CRISPR-powered_stocks\"><\/span>Wall Street rates CRISPR-powered stocks<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>CRISPR offers a relatively cheap and relatively method of editing practically any kind of DNA (animal or otherwise).<\/p>\n<p>As one might expect, it\u2019s\u00a0already triggered a myriad of moral, ethical, and legal troubles for scientists, but researchers say the tool could lead to cures for a wide array of genetic diseases.<\/p>\n<p><em>[Read:\u00a0Esports and gaming stocks are returning more profit than Bitcoin]<\/em><\/p>\n<figure class=\"post-image post-mediaBleed alignnone\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-1322419 size-full lazy\" alt=\"CRISPR, stocks\" width=\"1007\" height=\"757\" sizes=\"auto, (max-width: 1007px) 100vw, 1007px\" src=\"https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2020\/10\/Screenshot-2020-10-08-at-16.29.44.png\" data-lazy=\"true\" srcset=\"https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2020\/10\/Screenshot-2020-10-08-at-16.29.44.png 1007w, https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2020\/10\/Screenshot-2020-10-08-at-16.29.44-280x210.png 280w, https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2020\/10\/Screenshot-2020-10-08-at-16.29.44-359x270.png 359w, https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2020\/10\/Screenshot-2020-10-08-at-16.29.44-180x135.png 180w, https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2020\/10\/Screenshot-2020-10-08-at-16.29.44-796x598.png 796w, https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2020\/10\/Screenshot-2020-10-08-at-16.29.44-368x276.png 368w, https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2020\/10\/Screenshot-2020-10-08-at-16.29.44-736x552.png 736w, https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2020\/10\/Screenshot-2020-10-08-at-16.29.44-632x474.png 632w, https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2020\/10\/Screenshot-2020-10-08-at-16.29.44-536x402.png 536w\"\/><\/figure>\n<p>For what it\u2019s worth, Bank of America (BoA) finds the hype justified, at least in the short-term. BoA analysts\u00a0<a rel=\"nofollow noopener noreferrer\" target=\"_blank\" href=\"https:\/\/www.marketbeat.com\/instant-alerts\/nasdaq-crsp-a-buy-or-sell-right-now-2020-10\/\">reportedly issued<\/a> their first rating to CRSP earlier this week: \u201cBuy\u201d with a price target of $110 (current price $96).<\/p>\n<p>Goldman Sachs also rated NTLA for the first time last month when it labelled it a \u201cBuy\u201d and set its price target to $33 (current price $23), according to <a rel=\"nofollow noopener noreferrer\" target=\"_blank\" href=\"https:\/\/finviz.com\/quote.ashx?t=CRSP\">finance portal Finviz<\/a>.<\/p>\n<p><em>None of this is investment advice. Don\u2019t pretend it is, because it\u2019s not. Always do your own research.<\/em><\/p>\n<p class=\"c-post-pubDate\">\n                                    Published October 8, 2020 \u2014 16:01 UTC\n                                <\/p>\n<\/p><\/div>\n<p><script data-src=\"https:\/\/connect.facebook.net\/en_US\/sdk.js#xfbml=1&amp;appId=378011798897423&amp;version=v2.6\" id=\"socialSrcFacebook\" type=\"text\/template\"><\/script><\/p>\n<blockquote>\n<p style=\"text-align: center;\">For forums sites go to <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/forum.buradabiliyorum.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">Forum.BuradaBiliyorum.Com<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n<blockquote>\n<p style=\"text-align: center;\"><strong>If you want to read more like this article, you can visit our <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/en.buradabiliyorum.com\/technology\/\" target=\"_blank\" rel=\"noopener noreferrer\">Technology category.<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n<p><span style=\"color: black;\"><a style=\"color: #ff9900;\" href=\"https:\/\/thenextweb.com\/hardfork\/2020\/10\/08\/crispr-stocks-biotech-nobel-prize-chemistry-crsp-ntla-beam-edit\/\" target=\"_blank\" rel=\"noopener noreferrer\">Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;#CRISPR\u2019s Nobel Prize sent gene-editing stocks into overdrive&#8221; Biotech stocks continued to surge on Wednesday after two scientists responsible for gene-editing tool CRISPR\u00a0received this year\u2019s Nobel Prize for Chemistry. CRISPR-powered stocks Intellia Therapeutics (NTLA), Editas Medicine (EDIT), and Beam Therapeutics (BEAM) have now jumped 13%, 11%, and 6% respectively. CRISPR Therapeutics (CRSP), co-founded by one&#8230;<\/p>\n","protected":false},"author":1,"featured_media":84808,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/img-cdn.tnwcdn.com\/image\/hardfork?filter_last=1&fit=1280,640&url=https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2020\/10\/crispr.jpg&signature=2c31508ce9248f53b3b7b9dd7ceccb59","fifu_image_alt":"","footnotes":""},"categories":[18],"tags":[],"class_list":["post-84807","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/84807","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=84807"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/84807\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/84808"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=84807"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=84807"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=84807"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}